Crispr Therapeutics AG ( (CRSP) ) has fallen by -7.70%. Read on to learn why.

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1 Dose ...

Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found ...

A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

Biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP) isn't a name on many investors' radar -- and understandably so. Its ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

A team from UC San Diego, John Hopkins and UC Berkeley Universities found a way to edit a single gene in a mosquito that ...

CRISPR research is advancing at a rapid pace, and it can be hard to keep up. In only seven years, CRISPR went from an evolutionary adaptation in bacteria to a gene-editing tool that created the ...

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology. By Rebecca Sohn Updated Jul 28, 2021 5:01 PM EDT Get the Popular Science ...

Trained in the labs of Crispr inventors and pioneers, Janice Chen, Nicole Gaudelli, Omar Abudayyeh and Jonathan Gootenberg discuss the gene-editing trials they are working on, with the goal of ...